IRF1 and cancer: The main mechanism is that after treatment with SeNPs, elevated ROS accumulation in cancer cells activates TNF and interferon regulatory factor 1 (IRF1), which ultimately leads to an increase in RIP1 protein expression inducing necroptosis.182